Related Experiment Video
Updated: Aug 30, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Rheumatoid arthritis and atherosclerosis]
B Seriolo1, A Sulli, A Burroni
1Clinica Reumatologica, Dipartimento di Medicina Interna e Specialità Mediche, Università di Genova, Genova, Italia. seriolob@unige.it
Insights
Patients with rheumatoid arthritis (RA) face higher cardiovascular disease risks. Underlying factors like inflammation and specific biomarkers contribute to this increased risk, necessitating further research.
Area of Science:
- Rheumatology
- Cardiovascular Medicine
- Immunology
Context:
- Rheumatoid arthritis (RA) is associated with a significantly increased risk of cardiovascular disease (CVD) and mortality.
- The precise risk factors for coronary artery disease (CAD) in RA patients remain incompletely understood.
- Existing research suggests multifactorial contributors to atherogenesis in RA.
Purpose:
- To explore the multifaceted risk factors contributing to cardiovascular disease in rheumatoid arthritis patients.
- To elucidate the role of inflammation and specific biomarkers in RA-associated cardiovascular complications.
- To identify key factors influencing atherogenesis in the context of rheumatoid arthritis.
Summary:
- Accumulating evidence links rheumatoid arthritis (RA) to elevated risks of cardiovascular disease (CVD) and mortality.
- Potential risk factors include elevated homocysteine, antiphospholipid antibodies, altered lipoproteins, corticosteroid use, methotrexate, and hormonal factors.
- The inflammatory process inherent in RA is increasingly recognized as a contributor to atherosclerosis, with elevated pro-inflammatory cytokines correlating with future coronary events.
Impact:
- Highlights the critical need for comprehensive cardiovascular risk assessment in RA patients.
- Suggests potential therapeutic targets by identifying key atherogenic factors in RA.
- Emphasizes the link between chronic inflammation and cardiovascular pathology, relevant to other inflammatory diseases.
Abstract:
Evidence continue to accumulate indicating that patients with rheumatoid arthritis (RA) present an increased risk of cardiovascular disease (and death). The risk factors for coronary artery disease (CAD) in RA are not fully understood. However, a number of possible factors have been described, but more than one may be efficient, such as homocysteine, presence of antiphospholipid antibodies, altered serum levels of selected lipoproteins, and all together may have implications for the atherogenesis observed in these patients. Other factors that may facilitate this process, include corticosteroid use, methotrexate therapy and hormonal factors. However, the relative importance of these specific risk factors for the atherogenesis in this disease is poorly known. Recent findings indicate that cardiac death is increased in RA patients when compared with subjects without arthritis and that generally, the inflammatory process may contribute to atherosclerosis. In addition, other studies indicate that serum concentration of pro-inflammatory cytokines are found elevated at baseline, among patients at risk for future coronary occlusion.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
